Verition Fund Management
ABMD

Verition Fund Management’s Abiomed Inc ABMD Stock Holding History

Verition Fund Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,427
Closed -$351K – 3092
2022
Q3 		$351K Buy
1,427
+440
+45% +$119K ﹤0.01% 2117
2022
Q2 		$244K Buy
+987
New +$266K ﹤0.01% 1835
2021
Q4 		– Sell
-772
Closed -$251K – 2932
2021
Q3 		$251K Buy
+772
New +$262K ﹤0.01% 1530
2020
Q3 		– Sell
-1,365
Closed -$330K – 1451
2020
Q2 		$330K Buy
+1,365
New +$274K 0.01% 766
2020
Q1 		– Sell
-1,843
Closed -$314K – 1155
2019
Q4 		$314K Buy
1,843
+286
+18% +$53K 0.01% 810
2019
Q3 		$277K Buy
+1,557
New +$337K 0.01% 833
2019
Q2 		– Sell
-2,707
Closed -$773K – 1462
2019
Q1 		$773K Buy
+2,707
New +$900K 0.03% 495
2018
Q3 		– Sell
-1,245
Closed -$509K – 1488
2018
Q2 		$509K Sell
1,245
-4,581
-79% -$1.66M 0.03% 680
2018
Q1 		$1.7M Buy
+5,826
New +$1.48M 0.13% 192
2017
Q3 		– Sell
-2,246
Closed -$322K – 1435
2017
Q2 		$322K Buy
+2,246
New +$302K 0.03% 648
2016
Q3 		– Sell
-3,954
Closed -$432K – 1349
2016
Q2 		$432K Buy
+3,954
New +$393K 0.06% 445

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Verition Fund Management's ABMD Position: Q4 2022 in Review

Verition Fund Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,427 shares — an estimated $351K sold.

Verition Fund Management first reported a position in ABMD in Q2 2016 and held it in 11 quarters. The position peaked at $1.7M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Verition Fund Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 1,427 Abiomed Inc shares in Q4 2022, an estimated $351K.
  • Verition Fund Management first reported a position in Abiomed Inc in Q2 2016 and held it in 11 quarters.
  • Verition Fund Management's Abiomed Inc position peaked at $1.7M in Q1 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.